Hippocampus development and function: Role of epigenetic factors and implications for cognitive disease

Clinical Genetics

Volumn 78, Issue 4, 2010, Pages 321-333

  Lagali, P S ^a,b   Corcoran, C P ^a,b   Picketts, D J ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Chromatin remodelling; Cognitive disease; Epigenetics; Hippocampus; Intellectual disability; Learning and memory; Mental retardation

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA METHYLTRANSFERASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRAIN DEVELOPMENT; BRAIN FUNCTION; COGNITIVE DEFECT; DNA METHYLATION; EPIGENETICS; GENE MUTATION; HETEROZYGOSITY; HIPPOCAMPUS; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MEMORY; MENTAL DEFICIENCY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RETT SYNDROME; REVIEW;

ANIMALIA;

EID: 77956415882     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01503.x     Document Type: Review

References (139)

1. Hirabayashi Y, Gotoh Y. Epigenetic control of neural precursor cell fate during development. Nat Rev Neurosci 2010, 11(6):377-388.
2. Juliandi B, Abematsu M, Nakashima K. Chromatin remodeling in neural stem cell differentiation. Curr Opin Neurobiol 2010, 20:1-8.
3. Mehler MF. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol 2008, 86(4):305-341.
4. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000, 403(6765):41-45.
5. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128(4):693-705.
6. Inlow JK, Restifo LL. Molecular and comparative genetics of mental retardation. Genetics 2004, 166(2):835-881.
7. Gecz J, Shoubridge C, Corbett M. The genetic landscape of intellectual disability arising from chromosome X. Trends Genet 2009, 25(7):308-316.
8. Stevenson RE, Schwartz CE. X-linked intellectual disability: unique vulnerability of the male genome. Dev Disabil Res Rev 2009, 15(4):361-368.
9. van Bokhoven H, Kramer JM. Disruption of the epigenetic code: an emerging mechanism in mental retardation. Neurobiol Dis 2010, 39(1):3-12.
10. Tole S, Christian C, Grove EA. Early specification and autonomous development of cortical fields in the mouse hippocampus. Development 1997, 124(24):4959-4970.
11. Altman J, Bayer SA. Prolonged sojourn of developing pyramidal cells in the intermediate zone of the hippocampus and their settling in the stratum pyramidale. J Comp Neurol 1990, 301(3):343-364.
12. Nowakowski RS, Rakic P. The mode of migration of neurons to the hippocampus: a Golgi and electron microscopic analysis in foetal rhesus monkey. J Neurocytol 1979, 8(6):697-718.
13. Tyzio R, Represa A, Jorquera I. The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite. J Neurosci 1999, 19(23):10372-10382.
14. Angevine JB. Time of neuron origin in the hippocampal region. An autoradiographic study in the mouse. Exp Neurol 1965, 1-70. Oct (Suppl 2):
15. Bayer SA, Altman J. Hippocampal development in the rat: cytogenesis and morphogenesis examined with autoradiography and low level X irradiation. J Comp Neurol 1974, 158(1):55-80.
16. Pleasure SJ, Anderson S, Hevner R. Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron 2000, 28(3):727-740.
17. Hennou S, Khalilov I, Diabira D. Early sequential formation of functional GABAA and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus. Eur J Neurosci 2002, 16(2):197-208.
18. Seress L, Ribak CE. Postnatal development of CA3 pyramidal neurons and their afferents in the Ammon's horn of rhesus monkeys. Hippocampus 1995, 5(3):217-231.
19. Amaral DG, Dent JA. Development of the mossy fibers of the dentate gyrus: I. A light and electron microscopic study of the mossy fibers and their expansions. J Comp Neurol 1981, 195(1):51-86.
20. Altman J, Bayer SA. Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J Comp Neurol 1990, 301(3):365-381.
21. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965, 124(3):319-335.
22. Hsieh J, Eisch AJ. Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind. Neurobiol Dis 2010, 39(1):73-84.
23. Malenka RC. The long-term potential of LTP. Nat Rev 2003, 4(11):923-926.
24. Lynch MA. Long-term potentiation and memory. Physiol Rev 2004, 84(1):87-136.
25. Sweatt JD. Toward a molecular explanation for long-term potentiation. Learn Mem 1999, 6(5):399-416.
26. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron 2004, 44(1):5-21.
27. Barrett RM, Wood MA. Beyond transcription factors: the role of chromatin modifying enzymes in regulating transcription required for memory. Learn Mem 2008, 15(7):460-467.
28. Roth TL, Sweatt JD. Regulation of chromatin structure in memory formation. Curr Opin Neurobiol 2009, 19(3):336-342.
29. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006, 31(2):89-97.
30. Jung BP, Zhang G, Ho W. Transient forebrain ischemia alters the mRNA expression of methyl DNA-binding factors in the adult rat hippocampus. Neuroscience 2002, 115(2):515-524.
31. Filion GJ, Zhenilo S, Salozhin S. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 2006, 26(1):169-181.
32. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69(6):915-926.
33. Okano M, Bell DW, Haber DA. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99(3):247-257.
34. Feng J, Zhou Y, Campbell SL. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010, 13(4):423-430.
35. Golshani P, Hutnick L, Schweizer F. Conditional Dnmt1 deletion in dorsal forebrain disrupts development of somatosensory barrel cortex and thalamocortical long-term potentiation. Thalamus Relat Syst 2005, 3(3):227-233.
36. Hutnick LK, Golshani P, Namihira M. DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. Human Mol Genet 2009, 18(15):2875-2888.
37. Xu GL, Bestor TH, Bourc'his D. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999, 402(6758):187-191.
38. Levenson JM, Roth TL, Lubin FD. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 2006, 281(23):15763-15773.
39. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007, 53(6):857-869.
40. Nelson ED, Kavalali ET, Monteggia LM. Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 2008, 28(2):395-406.
41. Lubin FD, Roth TL, Sweatt JD. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 2008, 28(42):10576-10586.
42. Zhao X, Ueba T, Christie BR. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci U S A 2003, 100(11):6777-6782.
43. Chen RZ, Akbarian S, Tudor M. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27(3):327-331.
44. Guy J, Hendrich B, Holmes M. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001, 27(3):322-326.
45. Shahbazian M, Young J, Yuva-Paylor L. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35(2):243-254.
46. Collins AL, Levenson JM, Vilaythong AP. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 2004, 13(21):2679-2689.
47. Belichenko PV, Oldfors A, Hagberg B. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994, 5(12):1509-1513.
48. Bauman ML, Kemper TL, Arin DM. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995, 45(8):1581-1586.
49. Chapleau CA, Calfa GD, Lane MC. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol Dis 2009, 35(2):219-233.
50. Smrt RD, Eaves-Egenes J, Barkho BZ. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis 2007, 27(1):77-89.
51. Belichenko PV, Wright EE, Belichenko NP. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol 2009, 514(3):240-258.
52. Zhou Z, Hong EJ, Cohen S. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52(2):255-269.
53. Asaka Y, Jugloff DG, Zhang L. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 2006, 21(1):217-227.
54. Moretti P, Levenson JM, Battaglia F. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 2006, 26(1):319-327.
55. Chao HT, Zoghbi HY, Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56(1):58-65.
56. Nelson ED, Kavalali ET, Monteggia LM. MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol 2006, 16(7):710-716.
57. Allan AM, Liang X, Luo Y. The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits. Human Mol Genet 2008, 17(13):2047-2057.
58. Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet 2009, 43:559-599.
59. Chwang WB, O'Riordan KJ, Levenson JM. ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem 2006, 13(3):322-328.
60. Chwang WB, Arthur JS, Schumacher A. The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation. J Neurosci 2007, 27(46):12732-12742.
61. Koshibu K, Graff J, Beullens M. Protein phosphatase 1 regulates the histone code for long-term memory. J Neurosci 2009, 29(41):13079-13089.
62. Goldberg S, Visochek L, Giladi E. PolyADP-ribosylation is required for long-term memory formation in mammals. J Neurochem 2009, 111(1):72-79.
63. Gupta S, Kim SY, Artis S. Histone methylation regulates memory formation. J Neurosci 2010, 30(10):3589-3599.
64. Lin W, Zhang Z, Srajer G. Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. Dev Dyn 2008, 237(4):928-940.
65. Bu P, Evrard YA, Lozano G. Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Mol Cell Biol 2007, 27(9):3405-3416.
66. Yao TP, Oh SP, Fuchs M. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998, 93(3):361-372.
67. Oike Y, Takakura N, Hata A. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 1999, 93(9):2771-2779.
68. Maurice T, Duclot F, Meunier J. Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice. Neuropsychopharmacology 2008, 33(7):1584-1602.
69. Korzus E, Rosenfeld MG, Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 2004, 42(6):961-972.
70. Alarcon JM, Malleret G, Touzani K. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 2004, 42(6):947-959.
71. Tachibana M, Sugimoto K, Nozaki M. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 2002, 16(14):1779-1791.
72. Rayasam GV, Wendling O, Angrand PO. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J 2003, 22(12):3153-3163.
73. Schaefer A, Sampath SC, Intrator A. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 2009, 64(5):678-691.
74. Balemans MC, Huibers MM, Eikelenboom NW. Reduced exploration, increased anxiety, and altered social behavior: autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice. Behav Brain Res 2010, 208(1):47-55.
75. Kleefstra T, Brunner HG, Amiel J. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 2006, 79(2):370-377.
76. Zhao X, DA D, Lim WK. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell 2009, 17(2):210-221.
77. Petrij F, Giles RH, Dauwerse HG. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995, 376(6538):348-351.
78. Roelfsema JH, White SJ, Ariyürek Y. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005, 76(4):572-580.
79. Oliveira AM, Abel T, Brindle PK. Differential role for CBP and p300 CREB-binding domain in motor skill learning. Behav Neurosci 2006, 120(3):724-729.
80. Oliveira AM, Wood MA, McDonough CB. Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. Learn Mem 2007, 14(9):564-572.
81. Fischer A, Sananbenesi F, Wang X. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447(7141):178-182.
82. Akhtar MW, Raingo J, Nelson ED. Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J Neurosci 2009, 29(25):8288-8297.
83. Guan JS, Haggarty SJ, Giacometti E. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459(7243):55-60.
84. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem 2009, 78:273-304.
85. Tang L, Nogales E. Structures of SWI/SNF chromatin remodeling complexes and the mechanistic implications in transcription. Prog Biophys Mol Biol 2010, 102:122-128.
86. Berube NG, Mangelsdorf M, Jagla M. The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clinical Invest 2005, 115(2):258-267.
87. Seah C, Levy MA, Jiang Y. Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53. J Neurosci 2008, 28(47):12570-12580.
88. Hurd EA, Capers PL, Blauwkamp MN. Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome 2007, 18(2):94-104.
89. Layman WS, McEwen DP, Beyer LA. Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet 2009, 18(11):1909-1923.
90. van der Horst GT, van Steeg H, Berg RJ. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 1997, 89(3):425-435.
91. Murai M, Enokido Y, Inamura N. Early postnatal ataxia and abnormal cerebellar development in mice lacking xeroderma pigmentosum group A and Cockayne syndrome group B DNA repair genes. Proc Natl Acad Sci U S A 2001, 98(23):13379-13384.
92. Matsumoto S, Banine F, Struve J. Brg1 is required for murine neural stem cell maintenance and gliogenesis. Dev Biol 2006, 289(2):372-383.
93. Seo S, Herr A, Lim JW. Geminin regulates neuronal differentiation by antagonizing Brg1 activity. Genes Dev 2005, 19(14):1723-1734.
94. Seo S, Richardson GA, Kroll KL. The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD. Development 2005, 132(1):105-115.
95. Lessard J, Wu JI, Ranish JA. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 2007, 55(2):201-215.
96. Wu JI, Lessard J, Olave IA. Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 2007, 56(1):94-108.
97. Sharma RP, Grayson DR, Guidotti A. Chromatin, DNA methylation and neuron gene regulation-the purpose of the package. J Psychiatry Neurosci 2005, 30(4):257-263.
98. Gibbons RJ, Picketts DJ, Villard L. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome). Cell 1995, 80(6):837-845.
99. Vissers LE, van Ravenswaaij CM, Admiraal R. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004, 36(9):955-957.
100. Meira LB, Graham JM, Greenberg CR. Manitoba aboriginal kindred with original cerebro-oculo- facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene. Am J Hum Genet 2000, 66(4):1221-1228.
101. Kalscheuer VM, Tao J, Donnelly A. Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am J Hum Genet 2003, 72(6):1401-1411.
102. Kameshita I, Sekiguchi M, Hamasaki D. Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. Biochem Biophys Res Commun 2008, 377(4):1162-1167.
103. Mari F, Azimonti S, Bertani I. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005, 14(14):1935-1946.
104. Amir RE, Van den Veyver IB, Wan M. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23(2):185-188.
105. Huynh KD, Fischle W, Verdin E. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 2000, 14(14):1810-1823.
106. Ng D, Thakker N, Corcoran CM. Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet 2004, 36(4):411-416.
107. Sanchez C, Sanchez I, Demmers JA. Proteomics analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor. Mol Cell Proteomics 2007, 6(5):820-834.
108. Wood MA, Kaplan MP, Park A. Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn Mem 2005, 12(2):111-119.
109. Aizawa H, Hu SC, Bobb K. Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. Science 2004, 303(5655):197-202.
110. Qiu Z, Ghosh A. A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. Neuron 2008, 60(5):775-787.
111. Kim SY, Levenson JM, Korsmeyer S. Developmental regulation of Eed complex composition governs a switch in global histone modification in brain. J Biol Chem 2007, 282(13):9962-9972.
112. Montgomery RL, Hsieh J, Barbosa AC. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci U S A 2009, 106(19):7876-7881.
113. Froyen G, Corbett M, Vandewalle J. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet 2008, 82(2):432-443.
114. Liu Z, Oughtred R, Wing SS. Characterization of E3 histone, a novel testis ubiquitin protein ligase which ubiquitinates histones. Mol Cell Biol 2005, 25(7):2819-2831.
115. Ding N, Zhou H, Esteve PO. Mediator links epigenetic silencing of neuronal gene expression with X-linked mental retardation. Mol Cell 2008, 31(3):347-359.
116. Knuesel MT, Meyer KD, Donner AJ. The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator. Mol Cell Biol 2009, 29(3):650-661.
117. Risheg H, Graham JM, Clark RD. A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nat Genet 2007, 39(4):451-453.
118. Schwartz CE, Tarpey PS, Lubs HA. The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene. J Med Genet 2007, 44(7):472-477.
119. Baujat G, Rio M, Rossignol S. Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. Am J Hum Genet 2004, 74(4):715-720.
120. Douglas J, Hanks S, Temple IK. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 2003, 72(1):132-143.
121. Kurotaki N, Imaizumi K, Harada N. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 2002, 30(4):365-366.
122. Li F, Adam L, Vadlamudi RK. p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep 2002, 3(8):767-773.
123. Asrar S, Meng Y, Zhou Z. Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1). Neuropharmacology 2009, 56(1):73-80.
124. Zhang H, Webb DJ, Asmussen H. A GIT1/PIX/Rac/ PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J Neurosci 2005, 25(13):3379-3388.
125. Duclot F, Jacquet C, Gongora C. Alteration of working memory but not in anxiety or stress response in p300/CBP associated factor (PCAF) histone acetylase knockout mice bred on a C57BL/6 background. Neurosci Lett 2010, 475(3):179-183.
126. Kleine-Kohlbrecher D, Christensen J, Vandamme J. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol Cell 2010, 38(2):165-178.
127. Laumonnier F, Holbert S, Ronce N. Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J Med Genet 2005, 42(10):780-786.
128. Kesler SR, Simensen RJ, Voeller K. Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin-Lowry syndrome. Neurogenetics 2007, 8(2):143-147.
129. Poirier R, Jacquot S, Vaillend C. Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior. Behav Genet 2007, 37(1):31-50.
130. Sassone-Corsi P, Mizzen CA, Cheung P. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 1999, 285(5429):886-891.
131. Trivier E, De Cesare D, Jacquot S. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 1996, 384(6609):567-570.
132. Jensen LR, Amende M, Gurok U. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am J Hum Genet 2005, 76(2):227-236.
133. Tahiliani M, Mei P, Fang R. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 2007, 447(7144):601-605.
134. Field M, Tarpey PS, Smith R. Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly. Am J Hum Genet 2007, 81(2):367-374.
135. Lower KM, Turner G, Kerr BA. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet 2002, 32(4):661-665.
136. Shoichet SA, Hoffmann K, Menzel C. Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. Am J Hum Genet 2003, 73(6):1341-1354.
137. Kleefstra T, Yntema HG, Oudakker AR. Zinc finger 81 (ZNF81) mutations associated with X-linked mental retardation. J Med Genet 2004, 41(5):394-399.
138. Lugtenberg D, Yntema HG, Banning MJ. ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. Am J Hum Genet 2006, 78(2):265-278.
139. Tarpey PS, Smith R, Pleasance E. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 2009, 41(5):535-543.